Masao Nawata

Kitakyushu, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a long-term multicenter observational study.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 06, 2025

Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.

Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.

Journal: Scandinavian journal of rheumatology

Published: December 12, 2023

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.

Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study.

Journal: Rheumatology (Oxford, England)

Published: June 12, 2023

A case of giant cell arteritis complicated by polymyalgia rheumatica with scalp necrosis and refractory jaw claudication.

A case of giant cell arteritis complicated by polymyalgia rheumatica with scalp necrosis and refractory jaw claudication.

Journal: Modern rheumatology case reports

Published: July 19, 2022

Rituximab in remission induction and maintenance therapy for microscopic polyangiitis associated with gastric cancer: A case report.

Rituximab in remission induction and maintenance therapy for microscopic polyangiitis associated with gastric cancer: A case report.

Journal: Modern rheumatology case reports

Published: September 10, 2021

Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.

Ultrasound efficacy of targeted-synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: a multicenter prospective cohort study in Japan.

Journal: Scandinavian journal of rheumatology

Published: September 03, 2021

Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset.

Usefulness of ultrasound as a predictor of elderly-onset rheumatoid arthritis with polymyalgia rheumatica-like onset.

Journal: Modern rheumatology

Published: August 30, 2021

Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study.

Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study.

Journal: BMC rheumatology

Published: May 07, 2021

Short-term effectiveness of ixekizumab to refractory psoriatic arthritis with spondyloarthritis: two case reports.

Short-term effectiveness of ixekizumab to refractory psoriatic arthritis with spondyloarthritis: two case reports.

Journal: Modern rheumatology case reports

Published: October 22, 2020

Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.

Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.

Journal: Lupus

Published: September 11, 2020

Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.

Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.

Journal: Modern rheumatology case reports

Published: July 21, 2020

Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.

Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report.

Journal: Case reports in rheumatology

Published: February 08, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026